<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27884122</article-id>
<article-id pub-id-type="pmc">5123256</article-id>
<article-id pub-id-type="publisher-id">351</article-id>
<article-id pub-id-type="doi">10.1186/s12881-016-0351-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Assessment of copy number variations in 120 patients with Poland syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vaccari</surname>
<given-names>Carlotta Maria</given-names>
</name>
<address>
<email>carlotta.vaccari@libero.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tassano</surname>
<given-names>Elisa</given-names>
</name>
<address>
<email>eli.tassano@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torre</surname>
<given-names>Michele</given-names>
</name>
<address>
<email>micheletorre@ospedale-gaslini.ge.it</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gimelli</surname>
<given-names>Stefania</given-names>
</name>
<address>
<email>stefania.gimelli@hcuge.ch</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Divizia</surname>
<given-names>Maria Teresa</given-names>
</name>
<address>
<email>mariateresadivizia@unige.it</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romanini</surname>
<given-names>Maria Victoria</given-names>
</name>
<address>
<email>mvromanini@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bossi</surname>
<given-names>Simone</given-names>
</name>
<address>
<email>simone.bossi@studenti.unige.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Musante</surname>
<given-names>Ilaria</given-names>
</name>
<address>
<email>ilaria.musante@unige.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valle</surname>
<given-names>Maura</given-names>
</name>
<address>
<email>mauravalle@ospedale-gaslini.ge.it</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Senes</surname>
<given-names>Filippo</given-names>
</name>
<address>
<email>filipposenes@ospedale-gaslini.ge.it</email>
</address>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Catena</surname>
<given-names>Nunzio</given-names>
</name>
<address>
<email>NunzioCatena@ospedale-gaslini.ge.it</email>
</address>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bedeschi</surname>
<given-names>Maria Francesca</given-names>
</name>
<address>
<email>m.bedeschi@policlinico.mi.it</email>
</address>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baban</surname>
<given-names>Anwar</given-names>
</name>
<address>
<email>anwar.baban@opbg.net</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Calevo</surname>
<given-names>Maria Grazia</given-names>
</name>
<address>
<email>mariagraziacalevo@ospedale-gaslini.ge.it</email>
</address>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Acquaviva</surname>
<given-names>Massimo</given-names>
</name>
<address>
<email>massimo.acquaviva.78@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lerone</surname>
<given-names>Margherita</given-names>
</name>
<address>
<email>geneticamedica@unige.it</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ravazzolo</surname>
<given-names>Roberto</given-names>
</name>
<address>
<email>rravazzo@unige.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9310-6514</contrib-id>
<name>
<surname>Puliti</surname>
<given-names>Aldamaria</given-names>
</name>
<address>
<phone>+39-010-56362802</phone>
<email>apuliti@unige.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<aff id="Aff1"><label>1</label>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy </aff>
<aff id="Aff2"><label>2</label>Medical Genetics Unit, Istituto Giannina Gaslini, Genoa, Italy </aff>
<aff id="Aff3"><label>3</label>Pediatric Surgery Unit and Airway Team, Istituto Giannina Gaslini, Genoa, Italy </aff>
<aff id="Aff4"><label>4</label>Department of Genetic Medicine and Development, Geneva University Medical School, Geneva, Switzerland </aff>
<aff id="Aff5"><label>5</label>Plastic and Reconstructive Surgery, Pediatric Surgery Unit, Istituto Giannina Gaslini, Genoa, Italy </aff>
<aff id="Aff6"><label>6</label>Radiology Unit, Istituto Giannina Gaslini, Genoa, Italy </aff>
<aff id="Aff7"><label>7</label>Reconstructive Microsurgery and Hand Surgery Unit, Istituto Giannina Gaslini, Genoa, Italy </aff>
<aff id="Aff8"><label>8</label>Medical Genetics Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy </aff>
<aff id="Aff9"><label>9</label>U.O.S.D. Epidemiology and Biostatistics, Istituto Giannina Gaslini, Genoa, Italy </aff>
<aff id="Aff10"><label>10</label>Medical Genetics Unit, Istituto Giannina Gaslini, via G. Gaslini 5, 16148 Genoa, Italy </aff>
<aff id="Aff11"><label>11</label>Present Address: Department of Pediatric Cardiology and Cardiac Surgery, Bambino Gesù Children’s Hospital, Rome, Italy </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>25</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>25</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>17</volume>
<elocation-id>89</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Poland Syndrome (PS) is a rare congenital disorder presenting with agenesis/hypoplasia of the pectoralis major muscle variably associated with thoracic and/or upper limb anomalies. Most cases are sporadic, but familial recurrence, with different inheritance patterns, has been observed. The genetic etiology of PS remains unknown. Karyotyping and array-comparative genomic hybridization (CGH) analyses can identify genomic imbalances that can clarify the genetic etiology of congenital and neurodevelopmental disorders. We previously reported a chromosome 11 deletion in twin girls with pectoralis muscle hypoplasia and skeletal anomalies, and a chromosome six deletion in a patient presenting a complex phenotype that included pectoralis muscle hypoplasia. However, the contribution of genomic imbalances to PS remains largely unknown.</p>
</sec>
<sec>
<title>Methods</title>
<p>To investigate the prevalence of chromosomal imbalances in PS, standard cytogenetic and array-CGH analyses were performed in 120 PS patients.</p>
</sec>
<sec>
<title>Results</title>
<p>Following the application of stringent filter criteria, 14 rare copy number variations (CNVs) were identified in 14 PS patients in different regions outside known common copy number variations: seven genomic duplications and seven genomic deletions, enclosing the two previously reported PS associated chromosomal deletions. These CNVs ranged from 0.04 to 4.71 Mb in size. Bioinformatic analysis of array-CGH data indicated gene enrichment in pathways involved in cell-cell adhesion, DNA binding and apoptosis processes. The analysis also provided a number of candidate genes possibly causing the developmental defects observed in PS patients, among others <italic>REV3L,</italic> a gene coding for an error-prone DNA polymerase previously associated with Möbius Syndrome with variable phenotypes including pectoralis muscle agenesis.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>A number of rare CNVs were identified in PS patients, and these involve genes that represent candidates for further evaluation. Rare inherited CNVs may contribute to, or represent risk factors of PS in a multifactorial mode of inheritance.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s12881-016-0351-x) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keyword</title>
<kwd>Array comparative genomic hybridization</kwd>
<kwd>Congenital abnormalities</kwd>
<kwd>DNA copy number variation</kwd>
<kwd>Limb anomalies</kwd>
<kwd>Musculoskeletal diseases</kwd>
<kwd>Pectoralis muscles</kwd>
<kwd>Poland syndrome</kwd>
<kwd>Chromosome deletion</kwd>
<kwd>Chromosome duplication</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Italian Ministero della Salute </institution>
</funding-source>
<award-id>RF-2010-2314356</award-id>
<principal-award-recipient>
<name>
<surname>Puliti</surname>
<given-names>Aldamaria</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004702</institution-id>
<institution>Università degli Studi di Genova</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007496</institution-id>
<institution>Fondazione Cassa di Risparmio di Genova e Imperia</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>Poland Syndrome (PS, MIM173800) is a congenital disorder of the pectoralis major muscle. PS patients present with pectoralis muscle agenesis/hypoplasia, more frequently on the right side. PS can be associated with a variable degree of ipsilateral thoracic and/or upper limb anomalies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Incidence of PS has been reported between 1/20,000 and 1/30,000 births with a higher prevalence in males [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Today, PS etiopathogenesis is still unknown. One of the most common assumptions is that isolated pectoralis major muscle defects are included in the spectrum of anomalies postulated to result from disruption of blood supply in the embryonic subclavian and vertebral arteries [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Alternatively, PS may be due to the involvement of genes regulating embryonic development of pectoral girdle [<xref ref-type="bibr" rid="CR7">7</xref>]. Familial recurrence was observed in about 10% of cases with different inheritance patterns including autosomal dominant with incomplete penetrance, autosomal recessive, and X-linked [<xref ref-type="bibr" rid="CR1">1</xref>]. The presence of different genes whose mutations may account for clinical differences among subgroups of patients and for the different inheritance patterns observed could be hypothesized. Two recently reported cases of de novo deletions contribute to support the genetic origin of PS and suggests the involvement of the deleted regions in PS pathogenesis. A deletion of chromosome 11q12.3 in monozygotic twins both affected by PS [<xref ref-type="bibr" rid="CR8">8</xref>] and a large deletion of chromosome 6q21-q22.1 in a patient with a complex phenotype mainly characterized by mental disability and PS [<xref ref-type="bibr" rid="CR9">9</xref>]. Genomic imbalances and copy number variants (CNV) represent a main source of genetic variation in humans and contribute to different congenital and neurodevelopmental defects [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. However, the contribution of genomic imbalances to a broader number of PS patients has not been systematically studied. In this study, we performed karyotyping and array-CGH analysis of a large cohort of PS patients to discover novel chromosomal regions associated with this condition.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Patients</title>
<p>The present cohort comprises 120 patients with pectoralis muscle agenesis/hypoplasia, either isolated or with associated anomalies (clinical data are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>). Control population (in-house controls) comprises 200 patients affected by various disorders (mainly intellectual disabilities) admitted to the Medical Genetics Unit, Gaslini Institute, Genoa, Italy, between January 2008 and December 2015, and their healthy parents for a total of 600 control individuals with no clinically evident pectoralis muscle abnormalities nor other features usually reported to be associated with PS.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of clinical data of all 120 patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Clinical feature</th><th>Total patients 120</th></tr></thead><tbody><tr><td colspan="2">Gender</td></tr><tr><td> Females</td><td>44</td></tr><tr><td> Males</td><td>76</td></tr><tr><td colspan="2">Pectoralis major muscle features</td></tr><tr><td> Agenesis</td><td>51</td></tr><tr><td> Hypoplasia</td><td>69</td></tr><tr><td> Right-sided</td><td>71</td></tr><tr><td>  Males</td><td>44</td></tr><tr><td>  Females</td><td>27</td></tr><tr><td> Left-sided</td><td>49</td></tr><tr><td>  Males</td><td>33</td></tr><tr><td>  Females</td><td>16</td></tr><tr><td> Isolated form</td><td>42</td></tr><tr><td> With associated anomalies</td><td>78</td></tr><tr><td colspan="2">Associated anomalies</td></tr><tr><td> Pectus excavatum/carinatum</td><td>21</td></tr><tr><td> Rib anomalies</td><td>10</td></tr><tr><td> Clavicle defects</td><td>1</td></tr><tr><td> Vertebral defects</td><td>1</td></tr><tr><td> Craniosynostosis</td><td>1</td></tr><tr><td> Upper limb anomalies</td><td>57</td></tr><tr><td> Classic brachysyndactyly</td><td>24</td></tr><tr><td> Hypoplasia of upper limb and/or hand</td><td>28</td></tr><tr><td>Cerebellar malformations and intellectual disabilities</td><td>1</td></tr><tr><td>Poland-Möbius syndrome</td><td>1</td></tr></tbody></table></table-wrap>
</p>
<p>All patients were evaluated by a multidisciplinary team enclosing surgeons, radiologists, orthopaedic surgeons, and clinical geneticists to get a complete evaluation of the patient phenotype. The presence of additional anomalies as dysmorphic signs, and the presence of associated syndromic features were carefully evaluated by a team of clinical geneticists with experience in dysmorphology. PS specific features and the possible presence of additional anomalies were investigated in details by physical examination, followed by radiological/ultrasound examination.</p>
</sec>
<sec id="Sec4">
<title>Karyotyping and array-CGH analyses</title>
<p>Chromosome analysis was carried out on GTG-banded chromosomes at a resolution of 550 bands. Array-CGH analysis was performed using a genomic oligonucleotide-array with 13 kb (AMADID 022060) or 22 kb (AMADID 014698) (Human Genome Microarray Chip; Agilent Technologies, Palo Alto, CA, USA). Array data were analyzed using the Agilent Genomic Workbench Lite Edition Software 6.5.0.18. Aberration segments were reviewed using GRCh37 hg19 of UCSC Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/index.html">http://genome.ucsc.edu/index.html</ext-link>). We annotated all detected copy number variations (CNVs) and CNV-encompassed genes across public databases: Genomic Variants Database (DGV) (<ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv/app/home">http://dgv.tcag.ca/dgv/app/home</ext-link>), DECIPHER (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>), Clinical Genome Resource (ClinGen) and ISCA (<ext-link ext-link-type="uri" xlink:href="http://www.clinicalgenome.org/">http://www.clinicalgenome.org</ext-link>), OMIM (<ext-link ext-link-type="uri" xlink:href="http://www.omim.org/">http://www.omim.org</ext-link>), PubMed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed">http://www.ncbi.nlm.nih.gov/pubmed</ext-link>), and databases of mouse (MGD)(<ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/">http://www.informatics.jax.org</ext-link>) and zebrafish (ZFIN) (ZFIN, <ext-link ext-link-type="uri" xlink:href="http://zfin.org/">http://zfin.org</ext-link>) models.</p>
</sec>
<sec id="Sec5">
<title>CNV annotation</title>
<p>All detected CNVs were tested for inheritance by hybridization of the parental DNA with the same array platform. A CNV was classified as unreported if it differed from those already reported for involving one more gene and/or if it differed by at least 100 kb on either side or by a total of 100 kb on both sides. To assess the clinical significance of the detected CNVs, we followed the recommended steps from Miller and coll. [<xref ref-type="bibr" rid="CR15">15</xref>]. All imbalances classified as benign in the ClinGen and/or found in our internal database of healthy individuals were considered to be benign and excluded from further analysis. The remaining CNVs were classified into groups. Group I contains genomic imbalances classified as being variants of uncertain clinical significance (VOUS) because of their unclear possible pathogenicity. CNVs were further classified as VOUS likely pathogenic, if including genes with a possible correlation to the phenotype, or simply VOUS, those CNVs for which clinical interpretation remains uncertain. Group II contains pathogenic CNVs overlapping critical regions of known microdeletions or microduplications and/or involving genes already described as causing a phenotype. These CNVs are found in the publicly available DECIPHER (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>) and ISCA (<ext-link ext-link-type="uri" xlink:href="http://www.clinicalgenome.org/">www.clinicalgenome.org</ext-link>) databases and in published literature. Only VOUS, and VOUS likely pathogenic variants were further investigated.</p>
</sec>
<sec id="Sec6">
<title>Real-Time genomic qPCR</title>
<p>Validation by an independent assay, i.e. quantitative polymerase chain reaction (qPCR), was obtained for de novo and/or unreported CNVs identified in PS patients (Additional file <xref ref-type="media" rid="MOESM1">1</xref>) according to established protocols [<xref ref-type="bibr" rid="CR16">16</xref>]. Briefly, DNA from the patients was analyzed together with DNA from one healthy adult used as control. Primers were designed to amplify a region lying inside the deletion or duplication and one region flanking the CNV. A region on chromosome 12 encompassing the <italic>GAPDH</italic> gene (NM_002046.3) was used as internal control to determine copy number and normalize primer efficiency (primer sequences are available on request). qPCR was performed using the iCycler (Biorad, Hercules, CA) with Sybr Green, and the comparative DDCt method as previously described [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p>
</sec>
<sec id="Sec7">
<title>Bioinformatics and network analysis of genes included within CNVs</title>
<p>We searched for mutations affecting the identified CNV-genes, and possibly associated to genetic disorders and/or anomalous phenotype, through available public databases: OMIM, PubMed, UCSC, GeneCard (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org/">http://www.genecards.org/</ext-link>), ClinVar (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>).</p>
<p>We used GeneCodis3 [<xref ref-type="bibr" rid="CR18">18</xref>] to unveil enrichment of annotations. Genomic coordinates of altered regions were used to retrieve CNV overlapping genes from the hg19 RefSeq track of the UCSC genome browser. All the genes obtained from either duplicated or deleted regions were used as input in GeneCodis (Additional file <xref ref-type="media" rid="MOESM2">2</xref>). This tool allows the classification of genes according to their putative biological function by screening the Gene Ontology (GO), OMIM, Panther Pathway, and KEGG Pathway. In the analysis, the hypergeometric test was applied followed by the false discovery rate correction (FDR) with a cut-off of 5% to determine which annotations were significantly enriched. For GO analysis, various hierarchical levels of the annotation data structure were used. A graphical representation of the GeneCodis analysis results and of the possible interrelationship among the CNV-genes was obtained by using Cytoscape tool [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
</sec>
</sec>
<sec id="Sec8">
<title>Results</title>
<sec id="Sec9">
<title>Clinical phenotypes</title>
<p>Clinical data from 120 sporadic PS patients, 115 new and 5 already reported [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] were collected and their clinical features summarised in Table <xref ref-type="table" rid="Tab1">1</xref>. Rarely, PS patients can show associated anomalies involving other structures/organs [<xref ref-type="bibr" rid="CR20">20</xref>]. Overall, no dysmorphic signs or other anomalies were observed in these patients but one, who presented with associated Möbius syndrome features. This patient was referred to the Medical Genetics Unit of Istituto Gaslini Genoa at the age of 9 months showing the following anomalies: weight and head circumference &lt; 3<sup>rd</sup> centile; length at 5<sup>th</sup> centile; right facial nerve paralysis; epicanthic folds; micrognatia and cleft palate (Pierre Robin sequence, MIM261800); right abducens nerve paralysis; right auditory nerve paralysis; right upper limb hypoplasia; flexion deformity of the left elbow and the left wrist.</p>
</sec>
<sec id="Sec10">
<title>Genomic rearrangements identified in Poland syndrome patients</title>
<p>Karyotyping and array-CGH analyses were performed in all patients. This survey led to the identification of 14 different heterozygous chromosome anomalies in 14 different patients, notably the same alteration was never reported in more than one patient (Table <xref ref-type="table" rid="Tab2">2</xref>). The duplication of patient PS14 and the deletion of patient PS15 overlapped the same 1.8Mbp region on chromosome 16p13.1 causing a dosage imbalance of the same 12 RefSeq genes. Smaller deletions affecting chromosome 16p13.1 were found in two in-house controls, and chromosome 16p13.1 deletions and 16p13.1 duplications were reported in patients with intellectual disabilities [<xref ref-type="bibr" rid="CR21">21</xref>] and autism [<xref ref-type="bibr" rid="CR22">22</xref>], respectively, without any PS-associated clinical sign. Except for CNVs involving chromosome 16p13.1 region, CNV data of PS patients and in-house controls did not reveal any shared CNVs. The deletion of patient PS6 overlaps the <italic>AUTS2</italic> gene, a susceptibility candidate gene for autism that is not related to PS-involved tissues.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Genomic deletions and duplications detected in 19 patients with Poland syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Patients ID</th><th>Gender</th><th>Chr. band</th><th>Coordinates Hg19</th><th>Size (Mbp)</th><th>CNV</th><th>Possible candidate genes<sup>a</sup>
</th><th>Inh</th><th>Pectoralis muscle phenotype (L/R)/Additional anomalies (L/R)</th><th>Previous reports</th></tr></thead><tbody><tr><td>2</td><td>F</td><td>5p15.2</td><td>chr5:13266637-14011580</td><td align="char" char=".">0.74</td><td>Dup</td><td>
<italic>DNAH5, TRIO</italic>
</td><td>Mat</td><td>hypoplasia (L)/upper limb hypoplasia (L)</td><td>-</td></tr><tr><td>3</td><td>M</td><td>5p14.3</td><td>chr5:22187485-22740287</td><td align="char" char=".">0.55</td><td>Dup</td><td>
<italic>CDH12</italic>
</td><td>de novo</td><td>hypoplasia (R)/hand hypoplasia (R)</td><td>-</td></tr><tr><td>4<sup>b</sup>
</td><td>F</td><td>5p14.1-p13.3</td><td>chr5:27656463-29650802</td><td align="char" char=".">1.99</td><td>Del</td><td>
<italic>CDH6, CDH9</italic>
</td><td>Mat</td><td>hypoplasia (R)</td><td>-</td></tr><tr><td>5</td><td>M</td><td>6q21-q22.1</td><td>chr6:111777947-116488007</td><td align="char" char=".">4.71</td><td>Del</td><td>
<italic>REV3L, FYN, WISP3, LAMA4, MARCKS, FRK, COL10A1</italic>
</td><td>Nd</td><td>hypoplasia (R)/scoliosis/pectus excavatum/intellectual disability</td><td>(22)</td></tr><tr><td>6</td><td>F</td><td>7q11.22</td><td>chr7:70182803-70223737</td><td align="char" char=".">0.04</td><td>Del</td><td>
<italic>-</italic>
</td><td>de novo</td><td>agenesis (L)/brachysyndactyly (L)/ASD, pectus excavatum</td><td>-</td></tr><tr><td>7</td><td>F</td><td>9p24.2-p24.1</td><td>chr9:4152060-4627624</td><td align="char" char=".">0.48</td><td>Dup</td><td>
<italic>GLIS3</italic>
</td><td>Mat</td><td>agenesis (L)/upper limb hypoplasia (L)</td><td>-</td></tr><tr><td>9</td><td>F</td><td>11q12.3</td><td>chr11:63185662-63342369</td><td align="char" char=".">0.16</td><td>Del</td><td>
<italic>HRASLS5, RARRES3, HRASLS2, PLA2G16</italic>
</td><td>de novo</td><td>hypoplasia (R)/hand hypoplaisa, vertebral defects</td><td>(8)</td></tr><tr><td>10</td><td>M</td><td>11p14.1</td><td>chr11:28131098-28349712</td><td align="char" char=".">0.22</td><td>Del</td><td>
<italic>KIF18A</italic>
</td><td>Mat</td><td>hypoplasia (R)</td><td>-</td></tr><tr><td>11</td><td>F</td><td>12q21.31-q21.32</td><td>chr12:86018191-87432656</td><td align="char" char=".">1.41</td><td>Dup</td><td>
<italic>NTS</italic>
</td><td>Pat</td><td>hypoplasia (R)/brachydactyly</td><td>-</td></tr><tr><td>12</td><td>M</td><td>13q12.11-q12.12</td><td>chr13:22840054-24890143</td><td align="char" char=".">2.05</td><td>Del</td><td>
<italic>SGCG, SACS, SPATA13</italic>
</td><td>Mat</td><td>agenesis (R)/brachysyndactyly (R), pectus excavatum</td><td>-</td></tr><tr><td>14</td><td>F</td><td>16p13.11-p12.3</td><td>chr16:15256686-18546759</td><td align="char" char=".">3.29</td><td>Dup</td><td>
<italic>NDE1, MYH11, ABCC6, XYLT1</italic>
</td><td>Not mat</td><td>agenesis (R)/upper limb hypoplasia (R)</td><td>-</td></tr><tr><td>15</td><td>M</td><td>16p13.11-p12.3</td><td>chr16:15131723-16305736</td><td align="char" char=".">1.17</td><td>Del</td><td>
<italic>RRN3, NDE1, MYH11, ABCC6</italic>
</td><td>Nd</td><td>hypoplasia (R), pectus carinatum</td><td>-</td></tr><tr><td>16</td><td>F</td><td>16q22.3-q23.1</td><td>chr16:74087653-74519724</td><td align="char" char=".">0.43</td><td>Dup</td><td>
<italic>PSMD7, GLG1</italic>
</td><td>Mat</td><td>agenesis (L)/upper limb hypoplasia (L), rib defects</td><td>(1)</td></tr><tr><td>20</td><td>M</td><td>Xp11.22</td><td>chrX:53666883-54056673</td><td align="char" char=".">0.39</td><td>Dup</td><td>
<italic>HUWE1</italic>
</td><td>Mat</td><td>hypoplasia (R)</td><td>(1)</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Genes previously implicated in: muscle/limb/skeletal structure and/or development; blood vessel structure and/or development; cell junction organization; cell division. <sup>b</sup>In this case the deletion does not encompass any genes, however, since it overlaps 5′ regions of two genes, <italic>CDH6, CDH9</italic>, these genes were both enclosed in this table as their expression could be impaired by the deletion. Inh = inheritance</p></table-wrap-foot></table-wrap>
</p>
<p>The parental origin was assessed for 11 of identified CNVs: 3 occurred <italic>de novo</italic>, eight were inherited from a healthy parent (seven maternal, one paternal). Clinical evaluation excluded the presence of any thoracic anomalies in the parents of all PS patients, indeed, the parents of patients PS11 and PS12, suspected to present a slight form of pectoralis muscle hypoplasia, were further examined by ultrasound analysis that confirmed a normal phenotype for all of them.</p>
<p>One patient (PS2) carried a duplication, dup(5)(p15.2), resulting from translocation 46, XX, t(5;11)(p15.1;q21) inherited from his unaffected mother. This was the only chromosome anomaly identified by standard karyotyping, one additional PS patient presented with 47,XXY karyotype associated with Klinefleter syndrome. Of the fourteen identified anomalies, except for 16p13.11-p12.3 deletion and duplication in patient PS14 and PS15 respectively, 12 were not present in DGV or differed from the reported CNVs by at least 100 kbp and/or involved at least one more gene. No newly identified CNVs matched those reported in DECIPHER or ClinGen.</p>
</sec>
<sec id="Sec11">
<title>Annotation of genes within CNVs</title>
<p>Based on the RefSeq database, 119 genes were identified in either duplicated or deleted regions (CNV-genes), including CNV-encompassed genes, genes interrupted by CNVs, and the two genes flanking CNVs on both sides. These last genes were included in the study according to the hypothesis that CNVs could impair their expression by removing or duplicating or separating expression regulatory elements from the coding sequences (Additional file <xref ref-type="media" rid="MOESM2">2</xref>). We investigated each CNV-gene for mutations associated to known disorder and/or anomalous phenotype through the use of available public genetic databases. Only one gene, <italic>REV3L</italic>, resulted to be recently described as associated to one patient with PS features [<xref ref-type="bibr" rid="CR23">23</xref>]. Thirteen genes were known disease genes reported in OMIM.</p>
<p>To gain further insight into the deleterious effects of mutations involving all CNV-genes, we performed a complete analysis of phenotypes resulting from inactivation of CNV-gene murine and zebrafish orthologs. For 34 genes, at least one murine mutant has been reported and phenotypically characterized. Most reported mouse mutants presented defects in tissues different from those affected in PS. For each patient, CNV-genes that could be considered as PS candidate genes on the basis of their expression pattern or molecular function are showed in Table <xref ref-type="table" rid="Tab2">2</xref>.</p>
</sec>
<sec id="Sec12">
<title>Bioinformatic analysis of genes included within CNVs</title>
<p>All CNV-genes were analyzed by GeneCodis to search for a significant enrichment of annotations, which can be used as functional descriptor of the biological processes involved in PS. Sixty-one of the total genes were annotated using GeneCodis, unmapped genes consisted of poorly annotated non-coding RNAs. We identified significant enrichment of 8 biological categories (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig1">1</xref>), some of them, as those concerning mechanisms of chondrocyte and/or skeletal muscle development, blood coagulation, and DNA binding and apoptotic processes, relevant as candidate mechanisms contributing to PS development.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Biological processes associated with genes rearranged in patients with PS</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genes</th><th>Annotations</th><th>List size<sup>a</sup>
</th><th>Reference Support<sup>b</sup>
</th><th>Reference size<sup>c</sup>
</th><th>Hyp_c<sup>d</sup>
</th></tr></thead><tbody><tr><td>FYN, CDH6, CDH9, FRK, CDH12</td><td>Panther P00012: Cadherin signaling pathway (modular enrichment)</td><td>61</td><td>140</td><td>34208</td><td align="char" char=".">7.40x10<sup>-5</sup>
</td></tr><tr><td>FYN, TRIO, KIF18A, MYH11, FRK, TUBE1, ABCC6, KIAA0430, REV3L, DNAH5, ABCC1</td><td>GO 0000166: nucleotide binding (MF) (modular enrichment)</td><td>61</td><td>2120</td><td>34208</td><td align="char" char=".">3.70x10<sup>-3</sup>
</td></tr><tr><td>CDH6,HDAC2, CDH9,CDH12</td><td>Panther P00057: Wnt signaling pathway (modular enrichment)</td><td>61</td><td>280</td><td>34208</td><td align="char" char=".">4.05x10<sup>-3</sup>
</td></tr><tr><td>FYN, KIF18A, HDAC2</td><td>GO 0005515: protein binding (MF); GO 0007596: blood coagulation (BP) (modular enrichment)</td><td>61</td><td>251</td><td>34208</td><td align="char" char=".">1.92x10<sup>-2</sup>
</td></tr><tr><td>TRIO, LGALS12, PSMD7, TNFRSF19</td><td>GO:0006915, apoptotic process (BP) (modular enrichment)</td><td>61</td><td>594</td><td>34208</td><td align="char" char=".">3.02x10<sup>-2</sup>
</td></tr><tr><td>KIF18A, TUBE1, DNAH5</td><td>GO 0007018, microtubule-based movement (BP)</td><td>61</td><td>90</td><td>34208</td><td align="char" char=".">2.88x10<sup>-2</sup>
</td></tr><tr><td>GLG1</td><td>GO 0032330: regulation of chondrocyte differentiation (BP)</td><td>61</td><td>3</td><td>34208</td><td align="char" char=".">4.17x10<sup>-2</sup>
</td></tr><tr><td>MYH11</td><td>GO 0030241, skeletal muscle myosin thick filament assembly (BP)</td><td>61</td><td>3</td><td>34208</td><td align="char" char=".">4.17x10<sup>-2</sup>
</td></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <sup>a</sup>Total number of genes in the input CNV list. <sup>b</sup>Number of annotated genes in the reference list. <sup>c</sup>Total number of genes in the reference list. <sup>d</sup>Hyp_c = Corrected hypergeometric pValue using FDR procedure with a cut-off of 5% GeneCodis. BP = biological processes. MF = molecular function</p></table-wrap-foot></table-wrap>
<fig id="Fig1"><label>Fig. 1</label><caption><p>Graphical representation of the possible interrelationship among the CNV-genes. In this figure, CNV-genes (<italic>light blue rounded nodes</italic>) and enriched categories (<italic>green diamonds</italic>) identified by GeneCodis analysis and their possible relantionships are visualized by Cytoscape tool</p></caption><graphic id="MO1" xlink:href="12881_2016_351_Fig1_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec13">
<title>Discussion</title>
<p>Here we present the first comprehensive survey of CNVs in PS and provide a catalog of CNVs and candidate genes possibly implicated in the PS phenotype. Most of the novel rearrangements identified in this study were transmitted from unaffected parents. This is expected on the basis of incomplete penetrance observed in familial cases [<xref ref-type="bibr" rid="CR1">1</xref>] and indicates that these CNVs may act as susceptibility alleles rather than direct causes of PS. In our cohort of patients, CNVs involved different genomic regions and different genes, which indicates that each identified CNV can account for single specific cases. This lack of overlap can be due to a sampling issue, or one may hypothesize that, if more than one CNV is related to the disease, the genes involved in these CNVs are members of the same family and/or belong to the same pathways. To unveil possible interplays among identified CNV-genes, we performed a comprehensive bioinformatic analysis of CNVs identified in our patients (Tab. <xref ref-type="table" rid="Tab2">2</xref>). This analysis showed significant enrichment of proteins involved in cell adhesion, blood coagulation, chondrogenesis, asymmetric development, skeletal muscle structure, and nucleotide binding (Table <xref ref-type="table" rid="Tab3">3</xref>). For each category and/or according to their expression pattern and function, we present the most relevant genes based on their hypothetical role in PS. The complete lack of <italic>LAMA4</italic> caused in mice hemorrhages associated with capillary defects, adipose tissue alteration, and motor control impairment [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. These findings suggest that the deletion of <italic>LAMA4</italic>, by inducing hemorrhages during embryonic development, could cause a variety of defects, possibly including those observed in PS patients. This hypothesis is in line with that of disruption of blood supply during development as causative of PS [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The <italic>MYH11</italic> gene, encoding the contractile protein myosin, was found duplicated in patient PS14 and deleted in patient PS15, suggesting it could be a dosage-sensitive gene. <italic>MYH11</italic> missense mutations cause a dominant form of thoracic aortic aneurysm and/or aortic dissection (AAT4, MIM132900) and <italic>Myh11</italic> null mice exhibit dilated cardiomyopathy [<xref ref-type="bibr" rid="CR26">26</xref>]. No pectoralis muscle anomalies nor PS-associated bone defects have been reported in AAT4 patients or described in <italic>Myh11</italic> null mice. In our study, the cadherin signaling pathway resulted as the most significant among all analyzed categories and, notably, the <italic>CDH12</italic> spanned the breakpoint of a duplication originating de novo in one patient. Neither hereditary disease nor animal models are known for <italic>CDH12. Glg1</italic> null mice were found to die shortly after birth and about 30% of the few surviving mice had bone defects [<xref ref-type="bibr" rid="CR27">27</xref>]. Patients with deletion of <italic>DNAH5</italic> exhibit randomization of left-right body asymmetry as situs inversus, or partial transposition of the viscera as isolated dextrocardia. Asymmetry is also a major feature of PS and the combination of PS and isolated dextrocardia was described in 11% of PS patients [<xref ref-type="bibr" rid="CR28">28</xref>]. <italic>DNAH5</italic> was duplicated in patient PS2 who presented asymmetric development of pectoralis muscles and upper limbs, although without dextrocardia. No data have been reported on the effects of enhanced <italic>DNAH5</italic> expression, for instance due to gene duplication, so we cannot exclude that both mechanisms, i.e. deficiency as well as enhancement of <italic>DNAH5</italic> function, may induce asymmetric development. Asymmetric development was also observed in mice carrying inactivation of the <italic>Rrn3</italic> gene [<xref ref-type="bibr" rid="CR29">29</xref>]. The <italic>SGCG</italic> gene is associated with a recessive form of limb-girdle muscular dystrophy (LGMD2C, MIM253700). Of note, both PS and LGMD2C affect muscles of the limb-girdle.</p>
<p>An attractive candidate gene is <italic>TRIO,</italic> whose complete absence in mice causes embryonic lethality associated with abnormal development of skeletal muscle and neural tissues. Indeed, <italic>Trio</italic> deficiency caused a specific defect of myogenesis resulting in anomalies of skeletal muscle formation [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p>In fact, after consulting available genetic databases, OMIM, and PubMed, no mutations in any of the above mentioned genes have been previously reported as causing a phenotype resembling that showed by PS patients, except for one, the <italic>REV3L</italic> gene [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
<p>Mutations in the <italic>REV3L</italic> gene have been recently associated with Möbius syndrome (MBS) [<xref ref-type="bibr" rid="CR23">23</xref>], a rare congenital cranial dysinnervation disorder characterized by facial palsy and variable other congenital anomalies, including pectoralis muscle hypoplasia. Thomas-Roca and collaborators showed that mutations in <italic>REV3L</italic> are responsible for a proportion of MBS patients with highly variable clinical features and no obvious genotype–phenotype correlations. Accordingly, the pectoralis muscle agenesis was observed in only one among the three MBS patients carrying heterozygous <italic>REV3L</italic> mutations [<xref ref-type="bibr" rid="CR23">23</xref>]. The <italic>REV3L</italic> gene encodes a protein acting as catalytic subunit of DNA polymerase z, an error-prone DNA polymerase with a key role in replication of damaged DNA [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In the absence of <italic>REV3L</italic> [<xref ref-type="bibr" rid="CR33">33</xref>], unrepaired DNA damage triggers apoptosis via the accumulation of double-stranded DNA breaks. To explain the variability of phenotypes associated to the identified <italic>REV3L</italic> mutations in the MBS, Thomas-Roca and collaborators hypothesized that <italic>REV3L</italic> deficiency may result in a stochastic ablation of cell lineages during embryonic development, caused by replicative stress at endogenous DNA lesions and consequent DNA damage responses. According to this hypothesis, the appearance of the described PS-MBS associated phenotype in one <italic>REV3L</italic> mutation carrier may represent a very rare stochastic event. The description of a case carrying a deletion affecting the <italic>REV3L</italic> gene and showing a complex phenotype including PS without any apparent MBS signs (patient PS5) may support the hypothesis of mechanisms leading <italic>REV3L</italic> mutations to cause variable phenotypes but also seems to support a direct role of <italic>REV3L</italic> gene in pectoralis muscle development.</p>
</sec>
<sec id="Sec14">
<title>Conclusion</title>
<p>Data obtained by standard karyotype and array-CGH analyses in our cohort of 120 patients suggest that chromosome anomalies, duplications and deletions, are a rare cause of PS. Most of identified CNVs are inherited by unaffected parents, thus suggesting they could act as modifiers and represent risk factors of PS. Genes overlapped by the identified CNVs are enriched in functional categories and pathways involved in cell-cell adhesion, DNA binding and apoptosis processes, suggesting these processes as playing a role in PS development and indicating the identified genes as candidates for further evaluation in functional studies or mutation screening in other patients by direct sequencing or exome sequencing.</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec15">
<title>Additional files</title>
<p>
<media id="MOESM1" position="anchor" xlink:href="12881_2016_351_MOESM1_ESM.tif"><label>Additional file 1:</label><caption><p>
<bold>Figure S1.</bold> Quantitative polymerase chain reaction. In the Figure, examples of qPCR results obtained from three PS patients carrying three different CNVs are shown. A) Patient PS16: primers were designed to amplify a region encompassed by the duplication (chr16:74,313,856-74,313,966) and a 5′ flanking region (chr16:73,857,457-73,857,556); B) patient PS3: primers were designed to amplify a region encompassed by the duplication (chr5:22,539,039-22,539,170) and a 5′ flanking region (chr5:21,756,984-21,757,122); C) Patient PS10: primers were designed to amplify a region encompassed by the deletion (chr11:28,126,119-28,126,268) and a 5′ flanking region (chr11:28,075,866-28,076,003). Fold change of about 1 is expected for a diploid sample, about 0.5 for a haploid sample, and about 2.0 for a triploid sample. ctr: genomic DNA from one healthy adult used as control. (TIF 1168 kb)</p></caption></media>
<media id="MOESM2" position="anchor" xlink:href="12881_2016_351_MOESM2_ESM.docx"><label>Additional file 2:</label><caption><p>
<bold>Table S2.</bold> Annotated CNV-genes of PS patients. DUP = gene encompassed by a duplication; DEL = gene encompassed by a deletion; CNV-flanking gene = gene flanking a CNV; DUP-INTERRUPT = gene overlapping a duplication breakpoint. (DOCX 17.5 kb)</p></caption></media>
</p>
</sec>
</app>
</app-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Array-CGH</term>
<def>
<p>Array-comparative genomic hybridization</p>
</def>
</def-item>
<def-item>
<term>CNVs</term>
<def>
<p>Copy number variations</p>
</def>
</def-item>
<def-item>
<term>PS</term>
<def>
<p>Poland Syndrome</p>
</def>
</def-item>
<def-item>
<term>qPCR</term>
<def>
<p>Quantitative polymerase chain reaction</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<p>The authors wish to thank Dr G. Gimelli from the Medical Genetics Unit, Istituto Giannina Gaslini, Genoa, Italy, for providing scientific advice; Dr A. Capurro for revision of manuscript; the families and the AISP (Associazione Italiana Sindrome di Poland) for their participation and cooperation with this study.</p>
<sec id="FPar1">
<title>Funding</title>
<p>Funding for this research was provided by Italian Ministero della Salute (Project N. RF-2010-2314356 to A.P.; “Cinque per Mille” and Ricerca Corrente to R.R.), by University of Genoa “Progetto Ricerca Ateneo” (to A.P. and R.R.), and by Fondazione CARIGE.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>The authors declare that the data supporting the findings of this study are available within the article and its Additional files.</p>
<p>The databases used for this study have open access and their direct links can be found in the “<xref ref-type="sec" rid="Sec2">Methods</xref>” section.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>Conceived and designed the work: RR and AP. Carried out the clinical evaluation of the patients: CMV, MT, MTD, MVR, MV, FS, NC, MFB, AB, and ML. Performed the experiments: ET, SG, SB and IM. Contributed reagents, materials, analysis tools: ET, SG, AP, RR. Analysed the data: AP, CMV, MA, MGC. Wrote the paper: AP and RR. All authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Not relevant.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval and consent to participate</title>
<p>This study was approved by the Ethics Committee of the Giannina Gaslini Institute (Protocol number: RR_AP IGG 001). Written informed consent for analyses was obtained from all participating families, with the parents giving consent for themselves and on behalf of their minor children.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baban</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Costanzo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bianca</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Divizia</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Senes</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Garavelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rivieri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial Poland anomaly revisited</article-title>
<source/>Am J Med Genet A
          <year>2012</year>
<volume>158a</volume>
<issue>1</issue>
<fpage>140</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.34370</pub-id>
<pub-id pub-id-type="pmid">22110015</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catena</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Divizia</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Calevo</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Baban</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ravazzolo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Senes</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Hand and upper limb anomalies in Poland syndrome: a new proposal of classification</article-title>
<source/>J Pediatr Orthop
          <year>2012</year>
<volume>32</volume>
<issue>7</issue>
<fpage>727</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="doi">10.1097/BPO.0b013e318269c898</pub-id>
<pub-id pub-id-type="pmid">22955538</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freire-Maia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chautard</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Opitz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Freire-Maia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Quelce-Salgado</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The Poland syndrome-clinical and genealogical data, dermatoglyphic analysis, and incidence</article-title>
<source/>Hum Hered
          <year>1973</year>
<volume>23</volume>
<issue>2</issue>
<fpage>97</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1159/000152560</pub-id>
<pub-id pub-id-type="pmid">4356989</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGillivray</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Lowry</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>Poland syndrome in British Columbia: incidence and reproductive experience of affected persons</article-title>
<source/>Am J Med Genet
          <year>1977</year>
<volume>1</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320010108</pub-id>
<pub-id pub-id-type="pmid">205132</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bavinck</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>DD</given-names>
</name>
</person-group>
<article-title>Subclavian artery supply disruption sequence: hypothesis of a vascular etiology for Poland, Klippel-Feil, and Mobius anomalies</article-title>
<source/>Am J Med Genet
          <year>1986</year>
<volume>23</volume>
<issue>4</issue>
<fpage>903</fpage>
<lpage>918</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320230405</pub-id>
<pub-id pub-id-type="pmid">3008556</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beer</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Kompatscher</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hergan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Poland’s syndrome and vascular malformations</article-title>
<source/>Br J Plast Surg
          <year>1996</year>
<volume>49</volume>
<issue>7</issue>
<fpage>482</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1016/S0007-1226(96)90037-5</pub-id>
<pub-id pub-id-type="pmid">8983554</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valasek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Theis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>DeLaurier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hinits</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luke</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Otto</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Minchin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Christ</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cellular and molecular investigations into the development of the pectoral girdle</article-title>
<source/>Dev Biol
          <year>2011</year>
<volume>357</volume>
<issue>1</issue>
<fpage>108</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2011.06.031</pub-id>
<pub-id pub-id-type="pmid">21741963</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaccari</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Romanini</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Musante</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tassano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Divizia</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morovic</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ravazzolo</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo deletion of chromosome 11q12.3 in monozygotic twins affected by Poland Syndrome</article-title>
<source/>BMC Med Genet
          <year>2014</year>
<volume>15</volume>
<fpage>63</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-15-63</pub-id>
<pub-id pub-id-type="pmid">24885342</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tassano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mirabelli-Badenier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Veneselli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Puliti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vaccari</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Morana</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Porta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cuoco</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Clinical and molecular characterization of a patient with interstitial 6q21q22.1 deletion</article-title>
<source/>Mol Cytogenet
          <year>2015</year>
<volume>8</volume>
<fpage>31</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-015-0134-7</pub-id>
<pub-id pub-id-type="pmid">26052347</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgieva</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Milanova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Craddock</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McCarroll</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo CNVs in bipolar affective disorder and schizophrenia</article-title>
<source/>Hum Mol Genet
          <year>2014</year>
<volume>23</volume>
<issue>24</issue>
<fpage>6677</fpage>
<lpage>6683</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu379</pub-id>
<pub-id pub-id-type="pmid">25055870</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silversides</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Costain</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Migita</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rickaby</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways</article-title>
<source/>PLoS Genet
          <year>2012</year>
<volume>8</volume>
<issue>8</issue>
<fpage>e1002843</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002843</pub-id>
<pub-id pub-id-type="pmid">22912587</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Striano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paravidino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Malacarne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robbiano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Traverso</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pezzella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Belcastro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization</article-title>
<source/>Arch Neurol
          <year>2012</year>
<volume>69</volume>
<issue>3</issue>
<fpage>322</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2011.1999</pub-id>
<pub-id pub-id-type="pmid">22083797</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tassano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Divizia</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vaccari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Puliti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Thrombocytopenia-absent radius (TAR) syndrome due to compound inheritance for a 1q21.1 microdeletion and a low-frequency noncoding RBM8A SNP: a new familial case</article-title>
<source/>Mol Cytogenet
          <year>2015</year>
<volume>8</volume>
<fpage>87</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-015-0188-6</pub-id>
<pub-id pub-id-type="pmid">26550033</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbitsky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanna-Cherchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fasel</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kiryluk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wuttke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Kaskel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kottgen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Warady</surname>
<given-names>BA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic imbalances in pediatric patients with chronic kidney disease</article-title>
<source/>J Clin Invest
          <year>2015</year>
<volume>125</volume>
<issue>5</issue>
<fpage>2171</fpage>
<lpage>2178</lpage>
<pub-id pub-id-type="doi">10.1172/JCI80877</pub-id>
<pub-id pub-id-type="pmid">25893603</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Aradhya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Crolla</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>CJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<issue>5</issue>
<fpage>749</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id>
<pub-id pub-id-type="pmid">20466091</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>PIA</given-names>
</name>
<name>
<surname>Vaccari</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Terracciano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Doria-Lamba</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Facchinetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Priolo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ayuso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Jorge</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Santorelli</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>The metabotropic glutamate receptor 1, GRM1: Evaluation as a candidate gene for inherited forms of cerebellar ataxia</article-title>
<source/>J Neurol
          <year>2010</year>
<volume>257</volume>
<issue>4</issue>
<fpage>598</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-009-5380-3</pub-id>
<pub-id pub-id-type="pmid">19924463</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method</article-title>
<source/>Methods
          <year>2001</year>
<volume>25</volume>
<issue>4</issue>
<fpage>402</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
<pub-id pub-id-type="pmid">11846609</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabas-Madrid</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nogales-Cadenas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pascual-Montano</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics</article-title>
<source/>Nucleic Acids Res
          <year>2012</year>
<volume>40</volume>
<issue>Web Server issue</issue>
<fpage>W478</fpage>
<lpage>W483</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gks402</pub-id>
<pub-id pub-id-type="pmid">22573175</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smoot</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ruscheinski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Ideker</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Cytoscape 2.8: new features for data integration and network visualization</article-title>
<source/>Bioinformatics
          <year>2011</year>
<volume>27</volume>
<issue>3</issue>
<fpage>431</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btq675</pub-id>
<pub-id pub-id-type="pmid">21149340</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silengo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boffi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Lower extremity counterpart of the Poland syndrome</article-title>
<source/>Clin Genet
          <year>1999</year>
<volume>55</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-0004.1999.550107.x</pub-id>
<pub-id pub-id-type="pmid">10066030</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Kovel</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Trucks</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Helbig</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kluck</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>von Spiczak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ostertag</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies</article-title>
<source/>Brain
          <year>2010</year>
<volume>133</volume>
<issue>Pt 1</issue>
<fpage>23</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awp262</pub-id>
<pub-id pub-id-type="pmid">19843651</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Magnusdottir</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Morgen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Arnarsdottir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bjornsdottir</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Jonsdottir</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>OM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CNVs conferring risk of autism or schizophrenia affect cognition in controls</article-title>
<source/>Nature
          <year>2014</year>
<volume>505</volume>
<issue>7483</issue>
<fpage>361</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1038/nature12818</pub-id>
<pub-id pub-id-type="pmid">24352232</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomas-Roca</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tsaalbi-Shtylik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Altunoglu</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Verzijl</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Soria</surname>
<given-names>L</given-names>
</name>
<name>
<surname>van Beusekom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Roscioli</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in PLXND1 and REV3L cause Mobius syndrome</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>7199</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms8199</pub-id>
<pub-id pub-id-type="pmid">26068067</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thyboll</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kortesmaa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Soininen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Iivanainen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sorokin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Risling</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tryggvason</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Deletion of the laminin alpha4 chain leads to impaired microvessel maturation</article-title>
<source/>Mol Cell Biol
          <year>2002</year>
<volume>22</volume>
<issue>4</issue>
<fpage>1194</fpage>
<lpage>1202</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.22.4.1194-1202.2002</pub-id>
<pub-id pub-id-type="pmid">11809810</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaicik</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Thyboll Kortesmaa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moverare-Skrtic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kortesmaa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Soininen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bergstrom</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ohlsson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Rozell</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Emont</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Laminin alpha4 deficient mice exhibit decreased capacity for adipose tissue expansion and weight gain</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>10</issue>
<fpage>e109854</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0109854</pub-id>
<pub-id pub-id-type="pmid">25310607</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morano</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>GX</given-names>
</name>
<name>
<surname>Baltas</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Lamounier-Zepter</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lutsch</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kott</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haase</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Smooth-muscle contraction without smooth-muscle myosin</article-title>
<source/>Nat Cell Biol
          <year>2000</year>
<volume>2</volume>
<issue>6</issue>
<fpage>371</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1038/35014065</pub-id>
<pub-id pub-id-type="pmid">10854329</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyaoka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miyajima</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk)</article-title>
<source/>Development
          <year>2010</year>
<volume>137</volume>
<issue>1</issue>
<fpage>159</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1242/dev.041574</pub-id>
<pub-id pub-id-type="pmid">20023171</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baban</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buluggiu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Costanzo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bricco</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lerone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bianca</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gatti</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Senes</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dextrocardia in patients with Poland syndrome: phenotypic characterization provides insight into the pathogenesis</article-title>
<source/>J Thorac Cardiovasc Surg
          <year>2010</year>
<volume>139</volume>
<issue>5</issue>
<fpage>1177</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="doi">10.1016/j.jtcvs.2009.08.024</pub-id>
<pub-id pub-id-type="pmid">19909992</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Casanova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kiss</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grone</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Schutz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grummt</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis</article-title>
<source/>Mol Cell
          <year>2005</year>
<volume>19</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2005.05.023</pub-id>
<pub-id pub-id-type="pmid">15989966</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Brien</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Seipel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Medley</surname>
<given-names>QG</given-names>
</name>
<name>
<surname>Bronson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Streuli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2000</year>
<volume>97</volume>
<issue>22</issue>
<fpage>12074</fpage>
<lpage>12078</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.97.22.12074</pub-id>
<pub-id pub-id-type="pmid">11050238</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>A full-length cDNA of hREV3 is predicted to encode DNA polymerase zeta for damage-induced mutagenesis in humans</article-title>
<source/>Mutat Res
          <year>1999</year>
<volume>433</volume>
<issue>2</issue>
<fpage>89</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/S0921-8777(98)00065-2</pub-id>
<pub-id pub-id-type="pmid">10102035</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Sloun</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Varlet</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sonneveld</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boei</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Romeijn</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Eeken</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>De Wind</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage</article-title>
<source/>Mol Cell Biol
          <year>2002</year>
<volume>22</volume>
<issue>7</issue>
<fpage>2159</fpage>
<lpage>2169</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.22.7.2159-2169.2002</pub-id>
<pub-id pub-id-type="pmid">11884603</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schenten</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kracker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alt</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Rajewsky</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Pol zeta ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability</article-title>
<source/>J Exp Med
          <year>2009</year>
<volume>206</volume>
<issue>2</issue>
<fpage>477</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20080669</pub-id>
<pub-id pub-id-type="pmid">19204108</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>